Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing a phase 1 vaccine candidate to expand its RSV pipeline beyond mRNA.

RSV-Related Hospitalizations and Comorbidities: Two Surprises Here —A recent study examined several broad categories of comorbidities in an attempt to determine which ones correlated with ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests.

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond pulmonology, including poor kidney outcomes and cardiovascular conditions ...

While US regulators like the FDA have not launched an investigation, they do require all GLP-1s to carry warnings about the risk of acute pancreatitis and are monitoring for this side effect.

It’s summer in Georgia and months after Sine Die, when the state legislature finished sending bills to Gov. Brian Kemp for approval, or rejecting them, multiple new laws will take effect.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and diagnostic measures in healthcare.

Law & Government 10 of the Worst State Laws Going Into Effect in July From minimum wage hikes to bans on cellphones in public schools, here are some of the most ridiculous ways state governments ...

As the dust settles over the American missile and bomb craters in Iran, questions are already swirling about the success of the U.S. operation and the ripple effect it could have on the region and ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.